USPH vs MD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 20, 2026
USPH
MD
Investment Advisor Scores
MD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | USPH | MD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 27.248 | 9.2937 | MD |
| PEG Ratio | 2.7269 | 0.2433 | MD |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 8.5% | 4.0% | USPH |
| Earnings Growth | -56.5% | 6.5% | MD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.1/100 | 37.6/100 | USPH |
| Profit Margin | 4.0% | 9.0% | MD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | USPH |
Relative Price Performance (Last 90 Days)
Current Technical Phase
USPH
MarkupPrice above SMA50, rising 50-day trend (4.1% over 20 days), RSI 59
MD
MarkupPrice above SMA50, rising 50-day trend (0.6% over 20 days), RSI 66
Fundamentals Snapshot
| Metric | USPH | MD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 25.8 | 11.5 |
| Trailing P/E | 483.4 | 13.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.2% | 0.3% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 0.18 | 2.15 |
| Dividend Yield | 0.02% | — |